Global Retinal Vein Occlusion Therapeutics Market Status and Outlook 2018-2025

August 2018 | 139 pages | ID: G623717C1CEEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Acucela Inc
• Addmedica SAS
• Aerpio Therapeutics Inc
• Annexin Pharmaceuticals AB
• Chengdu Kanghong Pharmaceuticals Group Co Ltd
• Clearside BioMedical Inc
• Formycon AG
• Graybug Vision Inc
• Kala Pharmaceuticals Inc
• Lupin Ltd
• Mabion SA
• Novartis AG
• Ocular Therapeutix Inc
• Ohr Pharmaceutical Inc
• Regeneron Pharmaceuticals Inc
• SciFluor Life Sciences LLC
• ThromboGenics NV

Market by Type

• Aflibercept Biosimilar
• Aflibercept SR
• AKB-9778
• AP-01
• Others

Market by Application

• Research Center
• Clinic
• Hospital

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Retinal Vein Occlusion Therapeutics Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Aflibercept Biosimilar
  3.1.2 Aflibercept SR
  3.1.3 AKB-9778
  3.1.4 AP-01
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Research Center
  4.1.2 Clinic
  4.1.3 Hospital
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Aflibercept Biosimilar Production by Region
    6.1.1.2 Aflibercept SR Production by Region
    6.1.1.3 AKB-9778 Production by Region
    6.1.1.4 AP-01 Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Research Center Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Hospital Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Aflibercept Biosimilar Demand by Region
    6.2.1.2 Aflibercept SR Demand by Region
    6.2.1.3 AKB-9778 Demand by Region
    6.2.1.4 AP-01 Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Research Center Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Hospital Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Acucela Inc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Addmedica SAS
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Aerpio Therapeutics Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Annexin Pharmaceuticals AB
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Clearside BioMedical Inc
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Formycon AG
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Graybug Vision Inc
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Kala Pharmaceuticals Inc
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Lupin Ltd
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Mabion SA
8.12 Novartis AG
8.13 Ocular Therapeutix Inc
8.14 Ohr Pharmaceutical Inc
8.15 Regeneron Pharmaceuticals Inc
8.16 SciFluor Life Sciences LLC
8.17 ThromboGenics NV

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Retinal Vein Occlusion Therapeutics Industry Dynamics & Regulations List
Table Global Retinal Vein Occlusion Therapeutics Sales Revenue, Cost and Margin, 2015-2018E
Table Global Retinal Vein Occlusion Therapeutics Market Status by Type 2015-2018E, in USD Million
Table Global Retinal Vein Occlusion Therapeutics Market Status by Application 2015-2018E, in USD Million
Table Global Retinal Vein Occlusion Therapeutics Market Status by Application 2015-2018E, in Volume
Table Global Retinal Vein Occlusion Therapeutics Market by Region 2015-2018E, in USD Million
Table Global Retinal Vein Occlusion Therapeutics Market Share by Region in 2018, in USD Million
Table Global Retinal Vein Occlusion Therapeutics Market by Region 2015-2018E, in Volume
Table Global Retinal Vein Occlusion Therapeutics Market Share by Region in 2018, in Volume
Table Aflibercept Biosimilar Production Value by Region 2015-2018E, in USD Million
Table Aflibercept Biosimilar Production Volume by Region 2015-2018E, in Volume
Table Aflibercept SR Production Value by Region 2015-2018E, in USD Million
Table Aflibercept SR Production Volume by Region 2015-2018E, in Volume
Table AKB-9778 Production Value by Region 2015-2018E, in USD Million
Table AKB-9778 Production Volume by Region 2015-2018E, in Volume
Table AP-01 Production Value by Region 2015-2018E, in USD Million
Table AP-01 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Research Center Production Value by Region 2015-2018E, in USD Million
Table Research Center Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Aflibercept Biosimilar Market Size by Region 2015-2018E, in USD Million
Table Aflibercept Biosimilar Market Size by Region 2015-2018E, in Volume
Table Aflibercept SR Market Size by Region 2015-2018E, in USD Million
Table Aflibercept SR Market Size by Region 2015-2018E, in Volume
Table AKB-9778 Market Size by Region 2015-2018E, in USD Million
Table AKB-9778 Market Size by Region 2015-2018E, in Volume
Table AP-01 Market Size by Region 2015-2018E, in USD Million
Table AP-01 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Research Center Market Size by Region 2015-2018E, in USD Million
Table Research Center Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table GlobalRetinal Vein Occlusion Therapeutics Forecast by Type 2019F-2025F, in USD Million
Table Retinal Vein Occlusion Therapeutics Forecast by Type 2019F-2025F, in Volume
Table Retinal Vein Occlusion Therapeutics Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Retinal Vein Occlusion Therapeutics Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Retinal Vein Occlusion Therapeutics Market Forecast by Region 2019F-2025F, in USD Million
Table Retinal Vein Occlusion Therapeutics Market Forecast by Region 2019F-2025F, in Volume
Table Acucela Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Acucela Inc
Table Addmedica SAS Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Addmedica SAS
Table Aerpio Therapeutics Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Aerpio Therapeutics Inc
Table Annexin Pharmaceuticals AB Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Annexin Pharmaceuticals AB
Table Chengdu Kanghong Pharmaceuticals Group Co Ltd Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Chengdu Kanghong Pharmaceuticals Group Co Ltd
Table Clearside BioMedical Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Clearside BioMedical Inc
Table Formycon AG Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Formycon AG
Table Graybug Vision Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Graybug Vision Inc
Table Kala Pharmaceuticals Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Kala Pharmaceuticals Inc
Table Lupin Ltd Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Lupin Ltd
Table Mabion SA Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Mabion SA
Table Novartis AG Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Novartis AG
Table Ocular Therapeutix Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Ocular Therapeutix Inc
Table Ohr Pharmaceutical Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Ohr Pharmaceutical Inc
Table Regeneron Pharmaceuticals Inc Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of Regeneron Pharmaceuticals Inc
Table SciFluor Life Sciences LLC Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of SciFluor Life Sciences LLC
Table ThromboGenics NV Information
Table Retinal Vein Occlusion Therapeutics Sales, Cost, Margin of ThromboGenics NV
Table Global Retinal Vein Occlusion Therapeutics Sales Revenue by Company 2015-2017, in USD Million
Table Global Retinal Vein Occlusion Therapeutics Sales Volume by Company 2015-2017, in Volume
Table Global Retinal Vein Occlusion Therapeutics Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Retinal Vein Occlusion Therapeutics Picture
Figure Retinal Vein Occlusion Therapeutics Industry Chain Diagram
Figure Global Retinal Vein Occlusion Therapeutics Sales Revenue 2015-2018E, in USD Million
Figure Global Retinal Vein Occlusion Therapeutics Sales Volume 2015-2018E, in Volume
Figure Global Retinal Vein Occlusion Therapeutics Market Status by Type 2015-2018E, in Volume
Figure North America Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure North America Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Europe Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Europe Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure South America Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure South America Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Middle East Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Africa Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Africa Retinal Vein Occlusion Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Global Retinal Vein Occlusion Therapeutics Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Retinal Vein Occlusion Therapeutics Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Retinal Vein Occlusion Therapeutics Sales Price Forecast 2019F-2025F
Figure Global Retinal Vein Occlusion Therapeutics Gross Margin Forecast 2019F-2025F
Figure Global Retinal Vein Occlusion Therapeutics Sales Revenue by Company in 2018, in USD Million
Figure Global Retinal Vein Occlusion Therapeutics Price by Company in 2018
Figure Global Retinal Vein Occlusion Therapeutics Gross Margin by Company in 2018